210. Single Ventricle Clinical trials / Disease details
Clinical trials : 51 / Drugs : 53 - (DrugBank : 22) / Drug target genes : 32 - Drug target pathways : 67
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01291069 (ClinicalTrials.gov) | September 2011 | 4/2/2011 | Effect of Tadalafil on Exercise Capacity in Pediatric Fontan Patients | Effect of Tadalafil on Exercise Capacity in Pediatric Fontan Patients | Single Ventricle | Drug: Tadalafil Citrate;Drug: Sugar pill | University of Utah | NULL | Completed | 8 Years | 35 Years | All | 20 | Phase 1 | United States |